Pluss unveils Celsure XL VIP pallets
A game changing solution for the pharmaceutical industry
A game changing solution for the pharmaceutical industry
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This acquisition enables MTD to open new, strategic markets
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Subscribe To Our Newsletter & Stay Updated